Viatris Inc

Skip to main content

Company

Viatris Inc

32 results

BusinesscategoryIndia's Biocon Biologics says biosimilars put revenue on $1 bln trajectoryMay 24, 2023
BusinesscategoryViatris reaffirms 2023 sales forecast on strong demand for newer drugsMay 8, 2023
LegalcategoryUS Supreme Court spurns Sanofi appeal to revive EpiPen suit against ViatrisApril 17, 2023
LegalcategoryTeva, Viatris win U.S. appeal in patent fight over Parkinson's drugApril 12, 2023
Healthcare & PharmaceuticalscategoryGSK licenses companies to make cheap copies of HIV prevention drugMarch 30, 2023
BusinesscategoryViatris warns it will stop selling essential drugs in UK without changes to drug pricing agreementMarch 2, 2023
BusinesscategoryViatris names Scott Smith as CEO ahead of planned divestiture of certain businessesFebruary 27, 2023
WorldcategoryIndia's Biocon raises $129 mln from Kotak to fund biosimilars dealFebruary 22, 2023
Future of HealthcategoryWhy Europe's drug shortages may get worseFebruary 8, 2023
MarketscategoryIndia's Biocon sells 10% stake in Syngene via open market - filingFebruary 1, 2023
LegalcategoryU.S. Supreme Court rebuffs Novartis, allows generic versions of MS drugOctober 14, 2022
BusinesscategoryViatris weighs sale of consumer health assets in Europe - Bloomberg NewsOctober 11, 2022
LegalcategoryU.S. Supreme Court turns away Biogen bid to reinstate MS drug patentOctober 3, 2022
MarketscategoryEurope's generic drugmakers say they may cut output due to energy billsSeptember 28, 2022
Future of HealthcategoryBiogen leans on new Alzheimer's drug to calm investor worriesJuly 20, 2022
Future of HealthcategoryGeneric drugmakers sign on to make cheap version of Pfizer COVID pillMarch 17, 2022
MarketscategoryDeals of the day Mergers and acquisitionsFebruary 28, 2022
MarketscategoryAurinia Pharma, Tesla, Mullen, defense contractorsFebruary 28, 2022
BusinesscategoryEpiPen antitrust litigation settled; Viatris to pay $264 millionFebruary 28, 2022
MarketscategoryIndia's Biocon beefs up biosimilar portfolio with $3.34 bln Viatris deal, shares fallFebruary 28, 2022

1 to 20 of 32